All of the following are mentioned in the passage as reasons for allowing unlabeled uses of drugs EXCEPT ______.
A.
the increased cost to the patient of buying an FDA-approved drug
B.
the medical benefits which can accrue to the patient through unlabeled use
C.
the time lag between initial discovery of a medical use and FDA approval of that use
D.
the possibility that a medically beneficial use may never be clinically documented